NEW YORK (GenomeWeb News) – Prodesse today said that it has filed for US Food and Drug Administration 510(k) clearance of its ProParaflu+ assay.

The RT-PCR assay has been developed to rapidly detect and differentiate parainfluenza viruses 1, 2 and 3. The Milwaukee, Wis.-based firm said that the new assay is its third respiratory and fourth overall real-time assay that has been submitted for FDA clearance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Sponsored by

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.